Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

FDA highlights risks of evaluating blood pressure with unauthorized medical devices
The agency emphasized that many over-the-counter technologies marketed for this purpose have not been properly evaluated.
Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately
The FDA has categorized this as a Class I recall. If patients update their phone or watch apps as needed, they can continue to use these devices like normal.
Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes
Diets that prioritize plant-based foods are associated with several health benefits, according to a new study of more than 3.4 million adults. Such diets also show potential to reduce greenhouse gas emissions.
Health systems use AI to target patients who may have elevated Lp(a) levels
"We can start helping people right now, and it would be meaningful if we can raise more awareness to reduce the burden of CVD," explained Katherine Wilemon, founder and CEO of the Family Heart Foundation.
Oral GLP-1 drug linked to weight loss in patients with and without diabetes—is FDA approval next?
Eli Lilly and Company is back with even more positive data on orforglipron, its oral GLP-1 receptor agonist. The company says it is "moving with urgency" toward gaining key regulatory approvals and getting the drug in the hands of patients.

doctor with overweight patient who may be treated with TAVR or surgery

Are GLP-1 agonists safe? FDA finds no evidence popular weight loss medications cause suicidal thoughts or actions

The popular drugs, originally developed to treat diabetes, are being used more and more in the United States to help obese and overweight patients lose weight.

Eli Lilly and Company launches online marketplace with home delivery to combat ‘complex’ healthcare system

The news comes as more and more medications, including Lilly's own tirzepatide, are being used to treat both obesity and diabetes.

Regularly eating avocados is associated with a reduced risk of cardiovascular disease, according to a new study.

Top 15 heart-healthy diets: Experts call Mediterranean, DASH the best of the best

U.S. News has shared its annual ranking of the best diets for a person's heart. Weight Watchers, Jenny Craig and Noom are out in 2024, replaced by three different options that prioritize plant-based foods.

New drugs, updated treatment strategies: 5 important trends in cardiology from an eventful 2023

Revisit some of the year's biggest trends in the diagnosis, treatment and prevention of cardiovascular disease.

‘A true breakthrough’: The eye-opening potential of GLP-1 agonists to treat heart, kidney disease in addition to obesity

While GLP-1 drugs were originally developed to treat diabetes, researchers keep finding additional ways these medications can potentially benefit patients.

Newsweek ranked the 50 best heart hospitals in the world

Deaths from CVD are on the rise, cardiologists warn—high blood pressure, obesity remain 2 primary culprits

Cardiovascular disease remains one of the leading causes of mortality in the world, responsible for nearly 20 million deaths in 2022 alone.

artificial intelligence money finance acquisition

Medtronic backs out of $738M acquisition due to ‘multiple breaches’

Medtronic confirmed its decision in a statement, but did not provide any specific details. The deal was originally announced in May.

Statin therapy benefits high-risk patients with no prior history of CVD

Two separate studies examined the controversial topic of prescribing statins to high-risk elderly patients who do not already have high cholesterol or cardiovascular disease.

Heart Health

FDA highlights risks of evaluating blood pressure with unauthorized medical devices

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately

Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes

Health systems use AI to target patients who may have elevated Lp(a) levels

Oral GLP-1 drug linked to weight loss in patients with and without diabetes—is FDA approval next?